SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum

Neurology

Volumn 73, Issue 14, 2009, Pages 1111-1119

  Goizet, C ^b,c,d   Boukhris, A ^a,b,c,e   Maltete, D ^f   Guyant Marechal L ^f   Truchetto, J ^b,c   Mundwiller, E ^b,c   Hanein, S ^b,c   Jonveaux, P ^g   Roelens, F ^h   Loureiro, J ⁱ   Godet, E ^j   Forlani, S ^b,c   Melki, J ^k   Auer Grumbach, M ^l   Fernandez, J C ^b,c   Martin Hardy, P ^b,c   Sibon, I ^m   Sole, G ^m   Orignac, I ⁿ   Mhiri, C ^e   Coutinho, P ⁱ   Durr, A ^a,b,c   Brice, A ^a,b,c   Stevanin, G ^a   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (United States)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e HABIB BOURGUIBA HOSPITAL   (Tunisia)

^f ROUEN UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

^h Heilig Hart Ziekenhuis   (Belgium)

ⁱ Hospital So Sebastio   (Portugal)

^j Bon Secours Hospital   (France)

^k HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^l MEDICAL UNIVERSITY OF VIENNA   (Austria)

^m HÔPITAL PELLEGRIN   (France)

ⁿ NANTES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MESSENGER RNA; PROTEIN SPG15; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE COURSE; DISEASE SEVERITY; EXON; GENE MUTATION; GENE SEQUENCE; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WHITE MATTER;

EID: 70349753265     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181bacf59     Document Type: Article

References (29)

1. Stevanin G, Ruberg M, Brice A. Recent advances in the genetics of spastic paraplegias. Curr Neurol Neurosci Rep 2008;8:198-210.
2. Hedera P, Bandmann O. Complicated autosomal recessive hereditary spastic paraplegia: a complex picture is emerging. Neurology 2008;70:1375-1376.
3. Tallaksen CM, Durr A, Brice A. Recent advances in hereditary spastic paraplegia. Curr Opin Neurol 2001;14:457-463.
4. Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet 1983;1:1151-1155.
5. Durr A, Brice A. Clinical and genetic aspects of spinocere-bellar degeneration. Curr Opin Neurol 2000;13:407-413.
6. Coutinho P, Barros J, Zemmouri R, et al. Clinical heterogeneity of autosomal recessive spastic paraplegias: analysis of 106 patients in 46 families. Arch Neurol 1999;56:943-949.
7. Hehr U, Bauer P, Winner B, et al. Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. Ann Neurol 2007;62:656-665.
8. Depienne C, Stevanin G, Brice A, Durr A. Hereditary spastic paraplegias: an update. Curr Opin Neurol 2007;20: 674-680.
9. Lin P, Li J, Liu Q, et al. A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42). Am J Hum Genet 2008;83:752-759.
10. Casari G, De Fusco M, Ciarmatori S, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metallopro-tease. Cell 1998;93:973-983.
11. Engert JC, Berube P, Mercier J, et al. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet 2000;24:120-125.
12. Patel H, Cross H, Proukakis C, et al. SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nat Genet 2002;31:347-348.
13. Simpson MA, Cross H, Proukakis C, et al. Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet 2003;73:1147-1156.
14. Stevanin G, Santorelli FM, Azzedine H, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 2007;39: 366-372.
15. Hanein S, Martin E, Boukhris A, et al. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am J Hum Genet 2008;82:992-1002.
16. Tsaousidou MK, Ouahchi K, Warner TT, et al. Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet 2008;82:510-515.
17. Hughes CA, Byrne PC, Webb S, et al. SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q. Neurology 2001;56:1230-1233.
18. Kjellin K. Familial spastic paraplegia with amyotrophy, oligophrenia, and central retinal degeneration. Arch Neu-rol 1959;1:133-140.
19. Stevanin G, Azzedine H, Denora P, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 2008;131:772-784.
20. Boukhris A, Stevanin G, Feki I, et al. Hereditary spastic paraplegia with mental impairment and thin corpus callo-sum in Tunisia: SPG11, SPG15, and further genetic heterogeneity Arch Neurol 2008;65:393-402.
21. Noensie EN, Dietz HC. A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nat Biotechnol 2001;19:434-439.
22. Boukhris A, Feki I, Denis E, et al. Spastic paraplegia 15: linkage and clinical description of three Tunisian families. Mov Disord 2008;23:429-433.
23. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
24. Denora PS, Muglia M, Casali C, et al. Spastic paraplegia with thinning of the corpus callosum and white matter abnormalities: Further mutations and relative frequency in ZFYVE26/SPG15 in the Italian population. J Neurol Sci 2009;277:22-25.
25. Bauer P, Winner B, Schule R, et al. Identification of a heterozygous genomic deletion in the spatacsin gene in SPG11 patients using high-resolution comparative genomic hybridization. Neurogenetics 2009;10:43-48.
26. França MC Jr, D'Abreu A, Maurer-Morelli CV, et al. Prospective neuroimaging study in hereditary spastic paraplegia with thin corpus callosum. Mov Disord 2007;22:1556-1562.
27. Okubo S, Ueda M, Kamiya T, Mizumura S, Terashi A, Katayama Y. Neurological and neuroradiological progression in hereditary spastic paraplegia with a thin corpus cal-losum. Acta Neurol Scand 2000;102:196-199. (Pubitemid 30645139)
28. Liao SS, Shen L, Du J, et al. Novel mutations of the SPG11 gene in hereditary spastic paraplegia with thin corpus callosum. J Neurol Sci 2008;275:92-99.
29. Denora PS, Schlesinger D, Casali C, et al. Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. Hum Mutat 2009;30:E500-E519.